|
David Broecker serves as President and Chief Executive Officer for Alkermes. From 2001-2007, David held the position of President and Chief Operating Officer for Alkermes, overseeing all aspects of product research and development, regulatory, quality and manufacturing, business development, and commercialization of products. Prior to joining Alkermes, David held various positions during a 14 year tenure at Eli Lilly and Company where he worked throughout Lilly's worldwide operations including manufacturing, process development, sales, marketing, and business development in both the pharmaceutical division and former medical device division (Guidant Corporation). He is a graduate of Wabash College with a BA in chemistry and mathematics. He also holds graduate degrees from the Massachusetts Institute of Technology in chemical engineering and the University of Chicago in business administration. | 